Llwytho...
How to design preclinical studies in nanomedicine and cell therapy to maximize the prospects of clinical translation
The clinical translation of promising products, technologies and interventions from the disciplines of nanomedicine and cell therapy has been slow and inefficient. In part, translation has been hampered by suboptimal research practices that propagate biases and hinder reproducibility. These include...
Wedi'i Gadw mewn:
| Cyhoeddwyd yn: | Nat Biomed Eng |
|---|---|
| Prif Awduron: | , , |
| Fformat: | Artigo |
| Iaith: | Inglês |
| Cyhoeddwyd: |
2018
|
| Pynciau: | |
| Mynediad Ar-lein: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6436641/ https://ncbi.nlm.nih.gov/pubmed/30931172 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/s41551-018-0314-y |
| Tagiau: |
Ychwanegu Tag
Dim Tagiau, Byddwch y cyntaf i dagio'r cofnod hwn!
|